Your browser doesn't support javascript.
loading
Plasma ACE2 activity is persistently elevated following SARS-CoV-2 infection: implications for COVID-19 pathogenesis and consequences.
Patel, Sheila K; Juno, Jennifer A; Lee, Wen Shi; Wragg, Kathleen M; Hogarth, P Mark; Kent, Stephen J; Burrell, Louise M.
  • Patel SK; Dept of Medicine, Austin Health, University of Melbourne, Melbourne, Australia.
  • Juno JA; Contributed equally.
  • Lee WS; Dept of Microbiology and Immunology, University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.
  • Wragg KM; Contributed equally.
  • Hogarth PM; Dept of Microbiology and Immunology, University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.
  • Kent SJ; Dept of Microbiology and Immunology, University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.
  • Burrell LM; Immune Therapies Group, Burnet Institute, Melbourne, Australia.
Eur Respir J ; 57(5)2021 05.
Article en En | MEDLINE | ID: mdl-33479113
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Peptidil-Dipeptidasa A / COVID-19 Tipo de estudio: Etiology_studies Límite: Humans Idioma: En Año: 2021 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Peptidil-Dipeptidasa A / COVID-19 Tipo de estudio: Etiology_studies Límite: Humans Idioma: En Año: 2021 Tipo del documento: Article